Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
NVIDIA
NVDA
|
+$732M |
| 3 |
Amazon
AMZN
|
+$606M |
| 4 |
Walt Disney
DIS
|
+$559M |
| 5 |
AT&T
T
|
+$466M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$1.41B |
| 2 |
Comcast
CMCSA
|
+$658M |
| 3 |
Boston Scientific
BSX
|
+$650M |
| 4 |
Palo Alto Networks
PANW
|
+$642M |
| 5 |
T-Mobile US
TMUS
|
+$577M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.81% |
| 2 | Healthcare | 2.95% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.15% |
| 5 | Industrials | 1.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11451
PUT
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.5B
| $62.4K | ﹤0.01% |
1,200
-100
| -8% | -$4.94K |
|
11452
PUT
Unisys
UIS
$209M
| $62.4K | ﹤0.01% |
11,100
-24,500
| -69% | -$104K |
|
11453
PUT
NMI Holdings
NMIH
$3.44B
| $62.3K | ﹤0.01% |
2,100
-700
| -25% | -$19.5K |
|
11454
CALL
Beyond Air
XAIR
$5.61M
| $62.3K | ﹤0.01% |
80
+3
| +4% | +$2.34K |
|
11455
CALL
WidePoint Corp
WYY
$94.5M
| $62.2K | ﹤0.01% |
26,800
+24,800
| +1,240% | +$44.6K |
|
11456
PUT
Monte Rosa Therapeutics
GLUE
$1.32B
| $62.1K | ﹤0.01% |
+11,000
| New | +$43.2K |
|
|
FNA
11457
PUT
DELISTED
Paragon 28, Inc.
FNA
| $62.1K | ﹤0.01% |
5,000
+400
| +9% | +$4.23K |
|
11458
CALL
First Trust Health Care AlphaDEX Fund
FXH
$1.11B
| $62.1K | ﹤0.01% |
600
-2,400
| -80% | -$231K |
|
11459
PUT
Phathom Pharmaceuticals
PHAT
$775M
| $62.1K | ﹤0.01% |
6,800
+4,000
| +143% | +$34.5K |
|
11460
PUT
Schwab US Large- Cap ETF
SCHX
$74.9B
| $62K | ﹤0.01% |
3,300
+900
| +38% | +$15.8K |
|
11461
PUT
Arbutus Biopharma
ABUS
$924M
| $62K | ﹤0.01% |
24,800
+1,600
| +7% | +$3.13K |
|
|
NGM
11462
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $62K | ﹤0.01% |
72,174
-91,972
| -56% | -$80.8K |
|
11463
PUT
Oppenheimer Holdings
OPY
$1.25B
| $62K | ﹤0.01% |
1,500
-18,400
| -92% | -$704K |
|
11464
CALL
AdaptHealth
AHCO
$775M
| $62K | ﹤0.01% |
8,500
-37,300
| -81% | -$294K |
|
11465
CALL
VanEck High Yield Muni ETF
HYD
$4.4B
| $62K | ﹤0.01% |
1,200
-200
| -14% | -$9.91K |
|
11466
PUT
AMES National
ATLO
$280M
| $61.9K | ﹤0.01% |
2,900
+2,700
| +1,350% | +$49.4K |
|
11467
PUT
Arena Group
AREN
$54.8M
| $61.9K | ﹤0.01% |
26,000
+17,400
| +202% | +$57.4K |
|
11468
PUT
Global X SuperDividend US ETF
DIV
$786M
| $61.8K | ﹤0.01% |
3,600
-7,000
| -66% | -$114K |
|
11469
PharmaCyte Biotech
PMCB
$5.92M
| $61.8K | ﹤0.01% |
28,618
-6,766
| -19% | -$14.7K |
|
11470
Broadwind
BWEN
$127M
| $61.8K | ﹤0.01% |
22,313
+14,395
| +182% | +$38K |
|
|
PTVE
11471
CALL
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $61.7K | ﹤0.01% |
4,500
+3,400
| +309% | +$35.8K |
|
11472
PUT
VanEck Oil Refiners ETF
CRAK
$273M
| $61.6K | ﹤0.01% |
+1,800
| New | +$61.1K |
|
11473
PUT
iShares International Select Dividend ETF
IDV
$8.59B
| $61.6K | ﹤0.01% |
2,200
+2,000
| +1,000% | +$52.2K |
|
11474
PUT
Global X Cybersecurity ETF
BUG
$1.51B
| $61.6K | ﹤0.01% |
2,100
-5,600
| -73% | -$144K |
|
11475
Fortis
FTS
$29B
| $61.4K | ﹤0.01% |
1,494
-157,403
| -99% | -$6.35M |
|
Similar funds
Ken Griffin's Q4 2023 Portfolio in Review
As of Q4 2023, Ken Griffin held 15,795 positions worth $500B, up 7.2% from $467B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $25.4B in Q4 2023, closing 1,624 positions and reducing 6,315 holdings. Its most notable exit was Activision Blizzard, an estimated $1.41B position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Ken Griffin opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $129M.
- Ken Griffin's largest Q4 2023 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,167,658 shares worth $129M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $1.38B increase.
- Ken Griffin's biggest Q4 2023 reduction was Comcast, cutting an estimated $658M.
- Ken Griffin fully exited Activision Blizzard in Q4 2023, selling an estimated $1.41B.
- Ken Griffin's ten largest holdings make up 31% of its $500B portfolio in Q4 2023.
- Ken Griffin opened 1,585 new positions and closed 1,624 in Q4 2023.
- Ken Griffin's portfolio value rose 7.2% quarter-over-quarter to $500B.
Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.